Epigenome Programming by H3.3K27M Mutation Creates a Dependence of Pediatric Glioma on SMARCA4

Yan Mo1,2,3,4, Shoufu Duan1,2,3,4, Xu Zhang1,2,3,4

  • 1Institute for Cancer Genetics, Columbia University Irving Medical Center, New York, New York.

Cancer Discovery
|October 28, 2022
PubMed

Insights

Diffuse midline gliomas (DMG) with H3K27 alterations are aggressive. The study reveals SMARCA4 is crucial for DMG cell growth and tumor progression, suggesting it as a potential therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Epigenetics

Background:

  • Diffuse midline gliomas (DMG) with H3K27 alterations present a poor prognosis and undefined molecular drivers.
  • Current treatments for DMG are ineffective, highlighting the need for novel therapeutic strategies.

Discussion:

  • SMARCA4, a key component of the SWI/SNF chromatin remodeling complex, is demonstrated to be essential for DMG cell proliferation, migration, and invasion.
  • SMARCA4 interacts with SOX10 at gene regulatory elements, influencing the expression of genes critical for cell growth and extracellular matrix remodeling.
  • The binding of SMARCA4 to chromatin is dependent on SOX10 and the H3K27M mutation, with significant reduction observed upon H3K27M depletion.

Key Insights:

  • Epigenetic reprogramming by the H3K27M mutation creates a dependency on SMARCA4-mediated chromatin remodeling in DMG pathogenesis.
  • SMARCA4 plays a vital role in driving gene expression essential for the growth and progression of H3K27M-mutant DMG.
  • This research identifies SMARCA4 as a potential therapeutic target for H3K27M-mutant diffuse midline gliomas.

Outlook:

  • Targeting SMARCA4 could offer a novel therapeutic avenue for patients with deadly pediatric gliomas.
  • Further investigation into the precise mechanisms of SMARCA4 regulation in DMG is warranted.
  • Understanding the interplay between H3K27M, SOX10, and SMARCA4 may lead to more effective treatment strategies for diffuse midline gliomas.

Related Concept Videos

Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.1K
Genomic Imprinting and Inheritance02:30

Genomic Imprinting and Inheritance

Diploid organisms inherit genetic material through chromosomes from both parents. Copies of the same gene are known as alleles. In most cases, both alleles are simultaneously expressed and allow various cellular processes to function optimally. If one of the alleles is missing or mutated, the expression of the other allele can compensate; however, this is not true for all genes.
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
35.0K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
4.3K
Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.3K
Chromatin Modification in iPS Cells01:32

Chromatin Modification in iPS Cells

Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
1.8K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K